In the TGF-β/Smads signaling pathway, Smads protein is the signal transduction molecule downstream of the TGF-β receptor, and its gene mutation or abnormal protein expression can lead to blocked TGF-β signal, the disappearance of growth inhibition, and then reduced tumor inhibition [47]. Here, TGFB1 is linked to neoplasm.